The Omicron variant could prompt a reshuffling of the way doctors treat COVID infections in the United States, and antiviral pills will likely lead the way in that redoubled effort, Harvard experts say. New antiviral pills developed...

Cutting-edge mRNA technology brought safe, effective COVID-19 vaccines to a world in crisis — could it do the same for a much older foe, HIV? An experimental HIV vaccine that uses the same mRNA platform technology as...

Potent new antivirals may hold steady against Omicron. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the mutation-heavy variant, because they interfere with the ability of the coronavirus to replicate itself...

“Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate...

Cancer patients are at risk for serious COVID-19 illness, but some are still afraid to get vaccinated against the virus, new research shows. Study authors surveyed nearly 200 high-risk cancer patients at the Mays Cancer Center in...

U.S. operating rooms got busy once again soon after the first round of pandemic shutdowns, according to a study that challenges the widely held belief that operations have been curtailed indefinitely during the age of COVID-19. “It’s...

An overactive bladder isn’t just a nuisance and a source of embarrassment. For the elderly, it can also trigger a potentially fatal fall, a Canadian study says. “Falls are the leading cause of accidental death in seniors,...

Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma...

What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who...

The U.S. Centers for Disease Control and Prevention on Thursday backed the emergency approval of Pfizer’s booster shots for Americans aged 16 and 17. The decision came shortly after the U.S. Food and Drug Administration authorized a...